{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9H9S0",
      "entity_text" : "Nanog",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:6918454",
      "entity_text" : "PD184352",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Control inhibitors stabilize naive and primed pluripotent states as expected; LIF-Jak-Stat3 inhibition by ruxolitinib and tofacitinib promotes a primed signature (low Nanog, high Dnmt3b; XREF_FIG B), while the Fgfr inhibitors PD173074 and AZD4547 or the Mek1/2 inhibitors PD0325901 and PD184352 promote a naive signature (high Nanog, low Dnmt3b; XREF_FIG B).",
  "reading_complete" : "2020-08-08T13:05:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T13:03:08Z",
  "trigger" : "promote",
  "evidence" : [ "PD184352 promote a naive signature (high Nanog" ],
  "pmc_id" : "4987282",
  "score" : 0
}